Alembic Pharmaceuticals receives ANDA approval for Amantadine Hydrochloride Capsules
From USFDA
Alembic Pharmaceuticals has received approval from USFDA for its ANDA for Amantadine Hydrochloride Capsules, USP, 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product Symmetrel Capsules, 100 mg of Endo Pharmaceuticals Inc.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content